FDG PET/CT在非小细胞肺癌第八版TNM分期中的作用
本文综述肺癌第八版TNM分期系统的修订内容,包括基于肿瘤大小和范围的T分期重分配、新增M1b(单器官单发胸外转移)与M1c描述符,并阐述FDG PET/CT在非小细胞肺癌临床分期中的作用、各部位优势与局限。
要点
- 第八版TNM分期新增基于肿瘤大小和范围的T描述符,N描述符未变。
- 新增M1b(单器官单发胸外转移),与M1c(多发胸外转移)分开。
- FDG PET/CT是肺癌临床分期的标准诊疗手段和组成部分。
核心结论
- FDG PET/CT是肺癌标准诊疗手段,是临床分期的组成部分,放射科和核医学科医师应熟悉更新后的分期系统及各部位优势与局限。
研究设计与样本
- 综述性文章,回顾肺癌第八版TNM分期系统及FDG PET/CT在非小细胞肺癌分期中的作用,未报告系统检索范围与纳入文献数量。
诊断标准与关键数值
- 第八版T分期描述符基于组织病理学检查所见,并按肿瘤大小和范围重新分配。
- N描述符未变,仍按病变淋巴结位置分为四类N类别以预测预后。
- 新增M1b描述符用于单器官单发胸外转移病灶患者,其生存优于多发胸外转移(M1c)患者且治疗选择不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer is the leading cause of cancer-related mortality in the United States, and accurate staging plays a vital role in determining prognosis and treatment. The recently revised eighth edition of the TNM staging system for lung cancer defines new T and M descriptors and updates stage groupings on the basis of substantial differences in survival. There are new T descriptors that are based on the findings at histopathologic examination, and T descriptors are reassigned on the basis of tumor size and extent. No changes were made to the N descriptors in the eighth edition of the TNM staging of lung cancer, because the four N categories that are based on the location of the diseased nodes can be used to consistently predict prognosis. The eighth edition includes a new M1b descriptor for patients with a single extrathoracic metastatic lesion in a single organ (M1b), because they have better survival and different treatment options, compared with those with multiple extrathoracic lesions (M1c). Examination with fluorine 18 fluorodeoxyglucose (FDG) PET/CT is the standard of care and is an integral part of the clinical staging of patients with lung cancer. To provide the treating physicians with accurate staging information, radiologists and nuclear medicine physicians should be aware of the updated classification system and should be cognizant of the site-specific strengths and limitations of FDG PET/CT. In this article, the eighth edition of the TNM staging system is reviewed, as well as the role of FDG PET/CT in the staging of non-small cell lung carcinoma. ©RSNA, 2018.
引用
- Kandathil A, Kay FU, Butt YM, et al. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer. Radiographics. 2018. PMID: 30422775. doi:10.1148/rg.2018180060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。